Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02290626Withdrawn
Randomised, open-label trial in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Showa Inan General Hospital. Primary endpoint: Gastroesophageal regurgitation at 1 hour. Planned start Nov 2014; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02290626.